April 7, 2021
Via: BioSpaceRigel Pharmaceuticals, Inc.. (Nasdaq: RIGL) today announced the successful closing of its license agreement with Eli Lilly and Company (Lilly), following the expiration of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976. Rigel and Lilly entered […]
September 26, 2023
September 21, 2023
September 19, 2023
September 14, 2023
September 7, 2023
September 1, 2023
September 19, 2023
September 5, 2023